| Peak Healthcare At Sligo Creek | |
| 7525 Carroll Avenue, Takoma Park, Maryland 20912 | |
| (301) 270-4200 | |
| Name | Peak Healthcare At Sligo Creek |
|---|---|
| Location | 7525 Carroll Avenue, Takoma Park, Maryland |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 102 |
| Occupancy Rate | 75.49% |
| Medicare ID (CCN) | 215327 |
| Legal Business Name | Takoma Park Md Opco Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1154029726 |
| Organization Name | WOODSIDE PARK MD OPCO |
| Doing Business As | SLIGO CREEK HEALTHCARE |
| Address | 7525 Carroll Ave, Takoma Park, MD 20912 |
| Phone Number | 301-270-4200 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
California's bid to end court oversight of the care it gives about 33,000 mentally ill inmates was heard Wednesday by a federal judge who voiced concern that he had only days to weigh thousands of pages of contradictory claims and issue a decision (St. John, 3/27).
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 8 days ago
| NPI Number | 1598073645 |
| Organization Name | 7525 CARROLL AVENUE OPERATIONS LLC |
| Doing Business As | SLIGO CREEK CENTER |
| Address | 7525 Carroll Ave, Takoma Park, MD 20912 |
| Phone Number | 301-270-4200 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
California's bid to end court oversight of the care it gives about 33,000 mentally ill inmates was heard Wednesday by a federal judge who voiced concern that he had only days to weigh thousands of pages of contradictory claims and issue a decision (St. John, 3/27).
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 8 days ago
| NPI Number | 1598762767 |
| Organization Name | GENERAL CONFERENCE OF SEVENTH DAY ADVENTIST |
| Doing Business As | SLIGO CREEK NURSING & REHABILITATION CENTER |
| Address | 7525 Carroll Ave, Takoma Park, MD 20912 |
| Phone Number | 301-270-4200 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
California's bid to end court oversight of the care it gives about 33,000 mentally ill inmates was heard Wednesday by a federal judge who voiced concern that he had only days to weigh thousands of pages of contradictory claims and issue a decision (St. John, 3/27).
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 8 days ago
| NPI Number | 1760017560 |
| Organization Name | TAKOMA PARK MD OPCO LLC |
| Address | 7525 Carroll Ave, Takoma Park, MD 20912 |
| Phone Number | 301-270-4200 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
California's bid to end court oversight of the care it gives about 33,000 mentally ill inmates was heard Wednesday by a federal judge who voiced concern that he had only days to weigh thousands of pages of contradictory claims and issue a decision (St. John, 3/27).
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
California's bid to end court oversight of the care it gives about 33,000 mentally ill inmates was heard Wednesday by a federal judge who voiced concern that he had only days to weigh thousands of pages of contradictory claims and issue a decision (St. John, 3/27).
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 30.86 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.97 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.28 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.62 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.37 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 3 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.15 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 52.73 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.33 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.5 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 92.24 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.
A new study, "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision," shows that emergency department visits associated with over-the-counter pediatric cough cold medicines in children age 3 and younger have declined following voluntary industry labeling initiatives specifically designed to improve safe use in this age.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
California's bid to end court oversight of the care it gives about 33,000 mentally ill inmates was heard Wednesday by a federal judge who voiced concern that he had only days to weigh thousands of pages of contradictory claims and issue a decision (St. John, 3/27).
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
› Verified 8 days ago
Peak Healthcare At Sligo Creek Location: 7525 Carroll Avenue, Takoma Park, Maryland 20912 Phone: (301) 270-4200 |